Press release
Theranostics Market is Expected to Reach $4.3 Billion | MarketsandMarkets Trademark
Browse 94 market data Tables and 40 Figures spread through 196 Pages and in-depth TOC on "Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application
Theranostics market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to a latest report published by MarketsandMarkets Trademark . Market growth is attributed to the rising use of rising focus on precision medicine and increasing use of theranstics treatment for oncology applications.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111696976 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111696976&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Based on the product, the theranostics market is segmented into diagnostic imaging, radiopharmaceuticals, IVD/Biomarker screening, and software and services. The radiopharmaceuticals segment held the largest share of the theranostics market by product in 2022. The large share of this segment can be attributed to the rising use of radiopharmaceuticals and increasing awareness regarding early and accurate diagnosis.
Based on application, the theranostics market is segmented into prostate cancer, bone metastasis, other cancer, and other applications. Growth in this segment can be attributed to the rising incidence of prostate cancer and rising use of theranositcs for oncology applications. Over the last few years, the focus on targeted therapies is consistently rising. Recent approvals, rising investments, funds in this segment in the last few years are anticipated to drive the market growth.
Based on end user, the theranostics market is segmented into hospitals and cancer care centers, theranostics centers, and research and academic centers. Growth in this segment can be attributed to the increasing number of theranostics centers and rising adoption of therapy at the hospitals. Rising geriatric population and growing emphasis on maintaining health and well-being are anticipated to drive the market growth.
Based on region, North America accounts for the highest share of the theranostics market. This is due to strategic initiatives by the market players in the region, growing number of concerns regarding chronic diseases and rising initiatives by the government and private sector. The North America region has a higher adoption rate of the therapy as compared to other countries, which is a major factor responsible for the large share of the North America theranostics market. The rising incidence of cancer and rising focus of initiaties in the region are the other major factors responsible for the growth of the market.
Buy an Theranostics Industry Report (196 Pages PDF with Insightful Charts, Tables, and Figures): https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=111696976 [https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=111696976&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Theranostics market major players covered in the report, such as:
* Advanced Accelerator Applications (France)
* Bayer AG (Germany)
* GE Healthcare (US)
* Siemens Healthineers (Germany)
* and Cardinal Health (US)
* and Among Others
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=111696976 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=111696976&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
This report has segmented the global theranostics market based on product, application, end user, and region.
Global Theransotics Market, by Product
* Diagnostic Imaging
* Radiopharmaceuticals
* IVD/Biomarker Screening
* Software and Services
Global Theranostics Market, by Application
* Prostate Cancer
* Bone Metastasis
* Other Cancers
* Other Applications
Global Theranostics Market, by End User
* Hospitals and Cancer Care Centers
* Theranostics Centers
* Research and Academic Centers
Theranostics Market, by Region
* North America
* US
* Canada
* Europe
* Germany
* France
* UK
* Rest of Europe
* Asia Pacific
* Japan
* China
* India
* Rest of Asia Pacific
* Rest of the World
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=111696976 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=111696976&utm_source=globenewswire&utm_medium=referral&utm_campaign=paidpr]
Key Market Stakeholders:
* Senior Management
* End Users
* R&D Department
* Finance/Procurement Department
Report Objectives:
* To define, describe, and forecast the size of theranostics market based on product, application, end user, and region
* To provide detailed information regarding the major factors influencing the growth potential of the global theranostics market (drivers, restraints, opportunities, challenges, and trends)
* To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global theranostics market.
* To analyze key growth opportunities in the global theranostics market for key stakeholders and provide details of the competitive landscape for market leaders
* To forecast the size of market segments and/or subsegments with respect to three major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), and Rest of the World (Latin America and Middle East and Africa).
* To profile the key players in the theranostics market and comprehensively analyze their market shares and core competencies.
* To track and analyze the competitive developments undertaken in the global theranostics market, such as product launches; agreements; expansions; and mergers & acquisitions.
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=theranostics-market-is-expected-to-reach-43-billion-marketsandmarkets]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market is Expected to Reach $4.3 Billion | MarketsandMarkets Trademark here
News-ID: 3956818 • Views: …
More Releases from ABNewswire
Myasthenia Gravis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myasthenia Gravis pipeline constitutes 20+ key companies continuously working towards developing 22+ Myasthenia Gravis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Myasthenia Gravis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
SLIM CD Introduces Next-Generation Transaction Controls and Compliance Features …
SLIM CD introduces new transaction controls, PCI compliance reporting, tokenization management, and API governance, offering merchants greater security and flexibility. These updates help businesses stay compliant with evolving industry requirements while improving payment processing efficiency. Key features include tiered authorization thresholds, enhanced user experience, and EMV device compliance tools, all available immediately to SLIM CD merchants.
Coral Springs, FL - October 7, 2025 - SLIM CD, Inc., a leading payments software…
Stargardt Disease Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Ev …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Stargardt Disease pipeline constitutes 20+ key companies continuously working towards developing 20+ Stargardt Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Stargardt Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
Spinal Cord Injury Market Positioned for Accelerated Development Through 2034, D …
The Key Spinal Cord Injury Companies in the market include - Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others.
DelveInsight's "Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Spinal Cord Injury, historical and forecasted epidemiology as well as the Spinal Cord Injury market trends in…
More Releases for Theranostics
Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued…
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored…
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3…
Theranostics Market Worth $4.3 Billion | MarketsandMarkets Trademark
Theranostics Market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to…
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help…
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
